Concentrations of free vascular endothelial growth factor in the maternal and foetal circulations during pregnancy: A cross-sectional study

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 10, 2010, Pages 1244-1248

  Ali, Kamal Z ^a   Burton, Graham J ^b   Khalid, Mohammed E ^a   Moosa, Riyad ^a   Abd Alla, Salah ^a  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

free plasma VEGF; maternal and foetal blood; Placenta

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADOLESCENT; ADULT; ALTITUDE; ANGIOGENESIS; ARTICLE; CIRCULATION; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS CIRCULATION; HUMAN; MALE; MATERNAL CIRCULATION; NEWBORN; NORMAL HUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; SEX DIFFERENCE; SYNCYTIOTROPHOBLAST; UMBILICAL CORD BLOOD;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77953187737     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767050903511560     Document Type: Article

References (25)

1. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267: 10931-10934.
2. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995;11:73-91.
3. Risau W. Mechanisms of angiogenesis. Nature 1997;86: 671-674.
4. Kaufmann P, Bruns U, Leiser R, Luckhardt M, Winterhager E. The fetal vascularisation of term human placental villi. II.Intermediate and terminal villi. Anatomy and Embryology 1985;173:203-214. (Pubitemid 16182627)
5. Kaufmann P, Luckhardt M, Schweikhart G, Cantle SJ. Crosssectional features and three dimensional structure of human placental villi. Placenta 1987;8:235-247.
6. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenze GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor. Mol Cell Biol 1996;16:4604-4613.
7. Detmar M, Brown LF, Schön MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998;111:1-6.
8. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998;282:468-471.
9. Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L, Failla CM, Zambruno G. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci 2002;115:2559-2567.
10. Kendall RL, Wang G, and Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, Flt-1and its heterodimerization with KDR. Biochem Biophys Res Commun 1996;226:324-328.
11. Li H, Gu B, Zhang Y, Lewis DF, Wang Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 2005;26:210-217.
12. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Hackenberg C, Schweiger U, Born J, Fehm HL, Peters A. Acute hypoxia decreases plasma VEGF concentration in healthy humans. Am J Physiol Endocrinol Metab. 2006; 290(3):434-439.
13. Malamitsi-Puchner A, Tziotis J, Tsonou A, Protonotariou E, Sarandakou A, Creatsas G. Changes in serum levels of vascular endothelial growth factor in males and females throughout life. J Soc Gynecol Investig 2000;7:309-312.
14. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-439.
15. Malamitsi-Puchner A, Tziotis J, Protonotariou E, Sarandakou A, Creatsas G. Angiogenic factors in the perinatal period: diversity in biological functions reflected in their serum concentrations soon after birth. Ann N Y Acad Sci 2000;900:169-173.
16. Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, Schlembach D. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond) 2007;112:51-57.
17. Gunga HC, Kirsch K, Rocker L, Behn C, Koralewski E, Davila LH, Estrada MI, Johannes B, Wittels P, Jelkmann W. Vascular endothelial growth factor in exercising humans under different environmental conditions. Eur J Appl Physiol Occup Physiol 1999;79:484-490.
18. Ali KZM. Stereological study of the effect of altitude on the trophoblast cell populations of human placental villi. Placenta 1997;18:447-450.
19. Zamudio S, Baumann MU, and Illsley NP. Effects of chronic hypoxia in vivo on the expression of human placental glucose transporters. Placenta 2006;27:49-55. (Pubitemid 41662879)
20. Lawrence D. Longo. High altitude and pregnancy. LLU&MC Scope Autumn 1997. Available from: www.llu.edu/news/scope/aut97/alt.htm.
21. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350(7):672-683.
22. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke SW, Stillman IE, et al. Excess placental soluble fms like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-658.
23. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003;88:2348-2351.
24. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005;122: 33-39.
25. Wheeler T, Anthony FW, Young DA, Moore LG, Zamudio S. Maternal circulating vascular endothelial growth factor (VEGF) is elevated in high altitude pregnancy. J Soc Gynecol Investig 2002;9(Suppl):301A.